Skip to main content

DossiersBrian Thompson

◼ Public record

Mass Murderer Brian Thompson

CEO, UnitedHealthcare, April 2021 – December 4, 2024.

Annual compensation: $10.2M (2023) · UnitedHealthcare operating profit under his command: $16B (2023)

Brian Thompson was the CEO of UnitedHealthcare from April 2021 until his killing in Manhattan on December 4, 2024. During those forty-four months, the company he ran denied approximately one in three claims — roughly double the industry average— including through algorithmic systems that the company's own internal reviews flagged as wrong nine times out of ten on appeal. This dossier documents what happened under his command and asks what we are obligated to call it.

32%

In-network claim denials (2022) · 2× industry avg

90%

Appealed denials reversed · 0.2% ever appeal

$16B

UHC profit (2023) · 0 executives prosecuted

Ongoing

Algorithmic denial of care · 2021–2024

UnitedHealthcare denied 32% of in-network claims under Thompson — roughly double the industry average

When Brian Thompson became CEO of UnitedHealthcare in April 2021, he inherited the largest private health insurer in the United States — and deepened its model of claim denial as a profit mechanism. During his tenure, UnitedHealthcare's in-network claim denial rate reached approximately 32% — roughly double the industry average, per ProPublica and Senate Finance Committee data. He also presided over the full deployment of nH Predict, the AI algorithm purchased via naviHealth ($2.5B, 2020) that automatically denied post-acute-care coverage to elderly Medicare Advantage patients when their actual hospital stays exceeded the algorithm's predicted discharge dates. Thompson did not design the algorithm. He ran the company that deployed it at scale, booked the resulting profits, and received $10.2 million annually while doing so.

Ongoing

Patient harm — documented deaths · 2022–2024

Denial-by-design: elderly patients denied coverage over physician objection; two named plaintiffs died during the lawsuit

The federal class action Estate of Lokken v. UnitedHealth Group (D. Minn., 2023) documents what happens when the algorithm meets actual patients. Gene Lokken, 91, was denied skilled nursing coverage while his muscles were documented as "paralyzed and weak." Dale Tetzloff, 74, was denied after a stroke. Both families paid tens of thousands of dollars out of pocket. Both plaintiffs are now dead. Their cases are not anomalies; the complaint alleges a systematic scheme. The physician's recommendation was overridden by an algorithm Thompson chose to deploy. The profit was booked.

Alleged

Alleged insider trading · 2024

Thompson sold $15.1 million in UNH stock on Feb. 16, 2024 — eleven days before UNH disclosed a DOJ investigation that moved the stock

Eleven days before UnitedHealth Group publicly disclosed a Department of Justice investigation in February 2024 — triggering a stock drop — Brian Thompson sold $15.1 million in UNH shares. The timing is documented in SEC Form 4 filings. Multiple shareholder lawsuits were filed alleging Thompson and other executives sold stock on material non-public information. As of Thompson's death in December 2024, no criminal charges had been filed and no SEC enforcement action had been publicly announced. Thompson is deceased. The investigation record is unresolved.

  • February 16, 2024: Thompson sells $15.1 million in UNH stock, per SEC Form 4 filings.
  • February 21, 2024: Change Healthcare (UNH subsidiary) is struck by a ransomware attack — the largest health data breach in US history, affecting approximately one-third of all Americans' health records. Thompson and UNH leadership were informed as this unfolded.
  • February 27, 2024: UNH publicly discloses a DOJ investigation. Stock price falls.
  • The 11-day gap between the Thompson stock sale and the DOJ disclosure is the timeline on which multiple shareholder lawsuits are predicated. None have reached verdict.
  • The broader class action filed May 2024 (City of Hollywood Firefighters' Pension Fund) alleges Thompson and other executives sold a combined $120 million in UNH stock before the antitrust investigation became fully public. Witty + 2 other execs: $120M across an earlier window; Thompson's $15.1M falls within the same period of elevated DOJ scrutiny.
Ongoing

Catastrophic data breach · 2024

Change Healthcare ransomware attack (Feb. 2024): one-third of Americans' health data compromised; hospitals couldn't process claims for weeks

On February 21, 2024, ALPHV/BlackCat ransomware operators struck Change Healthcare — a UNH subsidiary acquired in 2022 for $13 billion. Change Healthcare processes roughly one-third of all US health insurance transactions. The attack halted claims processing at thousands of providers nationwide; hospitals couldn't verify coverage, pharmacies couldn't process prescriptions, and providers couldn't get paid for weeks. The breach compromised the health data of approximately 100 million Americans. Thompson and UNH CEO Andrew Witty testified before the Senate Finance Committee. Thompson was killed eight months later.

  • Change Healthcare processes approximately 15 billion healthcare transactions annually — roughly one-third of all US health insurance claims. Its incapacitation for weeks in spring 2024 caused cascading failures across the healthcare system.
  • Approximately 100 million Americans had protected health information exposed — names, Social Security numbers, diagnoses, insurance details. The largest healthcare data breach in US history.
  • Many small and rural providers — pharmacies, small practices — reported being unable to pay staff or cover operating costs for weeks due to the claims-processing halt.
  • Thompson testified before the Senate Finance Committee regarding the breach and UNH's response. He was one of two executives who appeared; UNH CEO Andrew Witty appeared separately.
  • Change Healthcare paid a $22 million ransom to ALPHV/BlackCat. The ransom payment did not prevent exposure of patient data. ALPHV subsequently folded and the data was later distributed by a splinter group.
  • The $13B acquisition in 2022 — approved by DOJ despite antitrust concerns — consolidated roughly one-third of the US health transaction infrastructure under a single insurer. The breach is a direct consequence of that consolidation.
Ongoing

Federal criminal and civil investigation · 2022–2024

DOJ investigating criminal Medicare Advantage fraud during Thompson's tenure — diagnosis upcoding to inflate federal payments

During Brian Thompson's tenure as CEO of UnitedHealthcare, UnitedHealth Group confirmed it had received both criminal and civil requests from the Department of Justice related to its Medicare Advantage billing practices. The investigation focuses on the systematic addition of high-value diagnoses to patient records without physician confirmation — a practice that inflates "risk scores" and drives higher federal payments per patient. The practice, if proven, would constitute Medicare fraud. No charges had been filed at the time of Thompson's death.

  • Medicare Advantage pays insurers per member, at a rate set by "risk score": the sicker the patient profile, the higher the federal payment. Inflating diagnoses — adding conditions patients don't have or haven't been treated for — inflates the payment without providing care.
  • The DOJ investigation was reported by the Wall Street Journal and confirmed by UnitedHealth. The company stated it was cooperating with both criminal and civil requests. The full scope of the investigation remained undisclosed as of late 2024.
  • A separate DOJ antitrust investigation — formally noticed October 2023 — examined whether the integration of UNH's insurance arm with Optum's 90,000+ physician group creates anticompetitive effects: the ability to steer patients and control treatment decisions.
  • Thompson oversaw the UnitedHealthcare subsidiary — the insurance arm — directly implicated in both investigations. He reported to UNH CEO Andrew Witty.
  • UNH's 2023 net income was $22.4 billion. Its Medicare Advantage business is the largest profit segment. If the fraud investigation yields charges, the financial benefit of the alleged conduct would be measured in billions.
Ongoing

The industry's own response — Section VIII · 2024–2025

Within 48 hours of Thompson's killing: insurers scrubbed executive pages. Within a year: UHC's denial rate fell 15 points. Both facts confirm the prior regime was a choice.

The health insurance industry's response to Thompson's death produced two documented facts that bear directly on the dossier's central argument. First: within 24–48 hours, major insurers simultaneously removed their executive leadership pages and photographs from public websites — an industry-wide acknowledgment that named executives were now personally identifiable in relation to the harm their companies produced. Second: UnitedHealthcare's ACA marketplace denial rate fell from 34.2% in Plan Year 2023 to 19.1% in Plan Year 2024 — the largest year-over-year improvement among major US insurers. If the prior denial level had been actuarially necessary — forced by claims costs, reserve requirements, or legal mandate — the improvement would have been impossible. It was not impossible. The industry found it possible when the alternative became visible.

  • Within 24–48 hours of Thompson's killing on December 4, 2024, UnitedHealth Group, Elevance Health (Anthem/Blue Cross Blue Shield), CVS/Aetna, Centene, and Humana removed or substantially redacted their executive leadership pages. Multiple Blue Cross Blue Shield regional plans — including North Carolina and Massachusetts — deleted leadership directories entirely.
  • Centene additionally moved its scheduled investor conference from in-person in New York to a virtual-only format. CVS confirmed the bio removals but declined to comment on the reasons. Elevance, Centene, and others did not respond to press inquiries.
  • Healthcare Dive and Fortune documented the removals with Wayback Machine snapshots confirming pages were live on December 4 and pulled within the following two days. The scale — simultaneous across competing companies with no coordinated public statement — is without modern parallel in the US insurance industry.
  • The structural reading: the executives did not fear one alleged shooter. They feared being named by a public that had stopped processing them as anonymous administrators of routine corporate decisions and had started processing them as individuals responsible for identifiable harm. The hiding is itself a form of acknowledgment.
  • UHC's ACA marketplace denial rate: 34.2% (2023) → 19.1% (2024), per federal CMS data analyzed by MoneyGeek and others. The 15-point improvement is the largest year-over-year drop among major US insurers. No actuarial event — no catastrophic claims year, no reserve mandate, no regulatory order — required this improvement. It happened. Which means the prior 34% level was not a floor; it was a policy.
Ongoing

The public verdict — Section IX · 2024–2025

41% of voters under 30 found Thompson's killing "acceptable." Working-class America refused to mourn. The public delivered the verdict courts wouldn't.

The public reaction to Thompson's killing was itself a story — and arguably the more politically significant one. An Emerson College poll conducted December 11–13, 2024 found that 41% of voters aged 18–29 considered the killing "somewhat or completely acceptable," while only 40% found it unacceptable. Among all voters, 17% found it acceptable. The generational split exposed something structural: the working class refused to perform mourning for a man whose company denied roughly one-third of claims, deployed an algorithm its own appeals process overturned nine times in ten, and booked $16 billion in profit while patients absorbed the denials. The legal system grants Thompson's class the dignity of presumed mourning. The public, on its own, revoked that grant.

  • Emerson College national poll (n=1,000 registered voters, Dec 11–13, 2024): Among voters aged 18–29: 41% found the killing "somewhat or completely acceptable" (24% somewhat; 17% completely), 40% found it unacceptable, 19% unsure. Among all voters: 17% acceptable, 68% unacceptable, 16% unsure. The 18–29 rate was nearly twice that of any other age group polled.
  • Shell casings recovered at the scene were found to have "delay," "deny," and "depose" written on them in Sharpie — referencing the vocabulary of insurance bad-faith criticism and the title of Jay Feinman's 2010 book critiquing the insurance industry. Police confirmed the markings as part of the evidence chain. (Initial press reports misidentified the third word as "defend"; law enforcement later confirmed it was "depose.")
  • Within days of Thompson's killing, online supporters raised more than $110,000 for Mangione's legal defense before crowdfunding platforms restricted the campaigns. "Free Luigi" merchandise — shirts, stickers, posters — proliferated across Etsy and other platforms, which were forced to moderate listings.
  • At Mangione's February 21, 2025 NYC court appearance, over a hundred supporters gathered outside the Manhattan criminal courthouse, chanting "Free Luigi" and "Stop denying — people are dying." The chants were audible from inside the 15th-floor courtroom. Supporters wore green — in solidarity with the Mario Bros. character Luigi. A "Free Luigi" billboard appeared in NYC ahead of the hearing. At his April 2025 federal arraignment, supporters again flooded the courthouse.
  • Trucks driving LED screens depicting people whose families say died because of insurance claim denials regularly accompany protests at Mangione's court dates — connecting the cultural moment explicitly to its systemic cause.
  • Taylor Lorenz appeared on CNN days after the killing, describing Mangione as a "morally good man" in the eyes of millions of Americans frustrated with the healthcare system — a statement that drew mainstream outrage and widespread recognition. US News, Newsweek, and others ran analyses framing the reaction as a generational class indictment of the healthcare system, not merely a crime story.
  • Documenting the reaction is not endorsing the killing. It is reporting that the public refused to be lied to about who Thompson was and what his company did. The legal system processes Thompson's death as murder while processing the deaths-by-denial as routine business. The public declined to honor that asymmetry.
Ongoing

Structural violence — the math · 2021–2024

$10.2 million per year. Claims processors: $45K. Two patients died appealing his algorithm. Zero executives charged.

Brian Thompson earned $10.2 million in total compensation in 2023 — the year UnitedHealthcare's denial rates peaked, two named plaintiffs in the class action died after coverage was cut, and the DOJ launched its criminal Medicare investigation. He earned this amount to run a subsidiary that denied roughly one-third of claims, deployed an algorithm the company's own appeal rates showed was wrong most of the time, and processed insurance for 49 million Americans. The claims processor who told a patient "we're still gonna say no" earned approximately $45,000. The nurse who reviewed the denials and was told to follow the algorithm earned approximately $80,000. The patients who died waiting for approval left families.

  • Thompson's $10.2M in total 2023 compensation included $1.27M base salary, $4M in non-equity incentive compensation, and $4.93M in stock awards.
  • CEO-to-median-worker pay ratio at UnitedHealth Group: approximately 352-to-1.
  • Stock buybacks across the US health insurance industry since 2010: approximately $120 billion. UnitedHealth Group's share: approximately $54 billion — 44% of the industry total.
  • The 2023 compensation proxy was filed and approved by the board while the nH Predict class action was active, while the DOJ investigation was ongoing, and while the ACA marketplace denial rate was 33% — the highest in the industry.
  • No UnitedHealth executive has been criminally charged in connection with the denial-of-care pattern, the Medicare fraud investigation, the insider trading allegations, or the Change Healthcare breach. Thompson died before any of these proceedings reached a verdict.

Editorial position

By what standard does the legal system process Thompson's death as murder while processing the deaths-by-denial as routine business?

The documented record above describes a pattern: an algorithm knowingly deployed at scale, generating automatic coverage denials at rates the company's own appeal process overturned nine times in ten — when patients could navigate it. Internal projections calculated the cost savings before the naviHealth acquisition closed. Employees were instructed to follow the algorithm over the judgment of treating physicians. The executives responsible for these decisions were compensated at eight-figure rates. Gene Lokken and Dale Tetzloff died while the lawsuit was pending. No one was charged.

Luigi Mangione allegedly shot Brian Thompson outside an investor conference. He faces first-degree murder charges. The deaths-by-denial produced no criminal proceedings. The mechanism that produced them is still operating under new management.

The legal asymmetry is not accidental. It reflects choices made by legislators, regulators, and prosecutors about which harms to criminalize, which actors to hold accountable, and whose deaths require a named perpetrator. The laws that make denial-driven profit legally defensible were written with sustained industry participation. The legal system is part of the apparatus this site is documenting, not the standard by which it is measured.

Editorial note: The 32% denial-rate figure is from ProPublica and Senate Finance Committee data for 2022. The nH Predict algorithm documentation is from the Senate PSI October 2024 report (280,000+ pages of internal UnitedHealth documents). The Lokken and Tetzloff cases are from the federal class action complaint (D. Minn., Nov. 2023). The McNaughton case documentation (recorded call, suppressed review) is from ProPublica's 2023 investigation. The stock sale timing is from SEC Form 4 public filings. The Change Healthcare breach timeline and scale is from UNH's own Senate testimony and DHHS Office for Civil Rights filings. "Mass murderer" is this site's editorial conclusion from those documented facts — not a legal verdict. Thompson was never charged with any crime. Corrections: corrections@billionairescrimes.com

Last updated: 2026-05-09 · Research: billionaires-research track

◼ List of charges

01

Price Gouging Causing Death

15life

Statute: Setting prices for life-saving goods or services at levels that foreseeably cause rationing, denial of access, and documented fatalities.

Basis: Presided as CEO over denial-by-design machine that denied ~32% of in-network claims (double industry average); deployed nH Predict algorithm known to be wrong ~90% of the time on appeal; two named plaintiffs (Lokken, Tetzloff) died after coverage cut over physician objection; ACA marketplace denial rate highest in industry at 33% (2023); $16B profit booked while patients absorbed denials

No jurors have rendered guilty yet

02

Insider Trading

515 years

Statute: Trading securities based on material non-public information in violation of fiduciary duty or securities law.

Basis: $15.1M in UNH stock sold February 16, 2024 — eleven days before public disclosure of DOJ investigation, five days before Change Healthcare breach announcement; multiple shareholder lawsuits filed; no criminal charges filed before Thompson's death

No jurors have rendered guilty yet

Total sentence

2093 years

That is

0.31.2 life sentences

(using 78 years as one life)

At $1 million per day

Thompson's fortune would last 21 years

0.3 lifetimes of luxury — before running out.

These are moral charges, not legal ones. The actual legal system never brought them.

WEEKLY DIGEST

New dossiers, new charges, verdict updates.

One email per week when there's something new to report. No filler.

No spam. Unsub anytime.